CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 3.160
  • +0.050+1.61%
15min DelayMarket Closed Dec 27 16:00 ET
222.17MMarket Cap-8.32P/E (TTM)

About NervGen Pharma Corp Company

NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.

Company Profile

SymbolNGEN
Company NameNervGen Pharma Corp
Founded2017
MarketTSX
Employees11
Fiscal Year Ends12-31
Address112-970 Burrard Street Unit 1290
CityVancouver
CountryCAN
Zip CodeV6Z 2R4
Phone+1 778 731-1711
Websitehttps://www.nervgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Kelly
  • Director, President and Chief Executive Officer
  • --
  • William J. Adams
  • Chief Financial Officer and Corporate Secretary
  • --
  • Dr. Daniel D. Mikol, M.D.
  • Chief Medical Officer
  • --
  • Glenn A. Ives
  • Chairman of the Board
  • --
  • Neil Klompas, C.A.,C.P.A.
  • Director
  • --
  • Dr. Adam H. Rogers, M.D.
  • Director
  • --
  • Brian Eric Bayley
  • Independent Director
  • --
  • Dr. Randall E. Kaye,M.D.
  • Independent Director
  • --
  • Dr. Harold M. Punnett
  • Independent Director
  • --
  • Krista L. McKerracher
  • Independent Director
  • --
  • Gianni Ruffolo
  • Independent Director
  • --
  • John Craig Thompson
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Price
% Chg

No Data